NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,102 | -4.6% | 3,388 | -5.5% | 0.09% | -3.1% |
Q2 2023 | $361,863 | +21.1% | 3,586 | +10.4% | 0.10% | +10.3% |
Q1 2023 | $298,908 | -37.2% | 3,249 | -38.0% | 0.09% | -40.4% |
Q4 2022 | $475,736 | +3.4% | 5,244 | -13.4% | 0.15% | -7.0% |
Q3 2022 | $460,000 | -11.0% | 6,054 | -1.1% | 0.16% | -8.7% |
Q2 2022 | $517,000 | -2.8% | 6,124 | +0.8% | 0.17% | +16.2% |
Q1 2022 | $532,000 | +97.0% | 6,074 | +96.5% | 0.15% | +111.4% |
Q4 2021 | $270,000 | -49.7% | 3,091 | -53.0% | 0.07% | -52.4% |
Q3 2021 | $537,000 | -9.0% | 6,578 | +1.7% | 0.15% | -12.0% |
Q2 2021 | $590,000 | +9.5% | 6,469 | +2.4% | 0.17% | +0.6% |
Q1 2021 | $539,000 | -13.8% | 6,315 | -4.7% | 0.17% | -16.6% |
Q4 2020 | $625,000 | +105.6% | 6,628 | +89.5% | 0.20% | +77.7% |
Q3 2020 | $304,000 | +1.3% | 3,498 | +1.8% | 0.11% | -9.7% |
Q2 2020 | $300,000 | +7.1% | 3,437 | +1.1% | 0.12% | -13.9% |
Q1 2020 | $280,000 | +16.2% | 3,398 | +33.3% | 0.14% | +56.5% |
Q4 2019 | $241,000 | – | 2,549 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |